GSK3B and diabetes mellitus: As the insulin signaling pathway controls the transport of glucose in hepatic cells, the dysregulation of IRS/AKT/GSK-3β insulin signaling pathway is a key determinant of the glycemic response showed in uncontrolled diabetes.